Related Experiment Video
Updated: Aug 6, 2026
11:12
Optimization of a Multiplex RNA-based Expression Assay Using Breast Cancer Archival Material
Published on: August 1, 2018
Multiplexed Detection of Breast Cancer-Specific miRNA and Protein Biomarkers on Exosomes Using a Microfluidic
Hongqiang Wang1, Hui Liu1, Yanan Luan1
1State Key Laboratory of Chemo and Biosensing, College of Chemistry and Chemical Engineering, Key Laboratory for Bio-Nanotechnology and Molecular Engineering of Hunan Province, Hunan University, Changsha410082, China.
Analytical Chemistry
|July 23, 2026
Summary
A novel microfluidic chip detects multiple breast cancer biomarkers from exosomes, significantly improving early diagnosis accuracy. This multitarget approach offers a sensitive, low-cost tool for cancer screening and treatment monitoring.
Area of Science:
- Biomedical Engineering
- Oncology
- Nanotechnology
Background:
- Exosomes are promising biomarkers for early cancer detection via liquid biopsy.
- Single biomarker detection limits accuracy, necessitating multi-biomarker strategies for precise diagnosis.
- Breast cancer diagnosis requires sensitive and specific screening tools.
Purpose of the Study:
- To develop a microfluidic chip for simultaneous detection of multiple exosomal biomarkers for breast cancer.
- To integrate chemiluminescence and fluorescence signals for enhanced detection sensitivity.
- To improve diagnostic accuracy for early breast cancer identification.
Main Methods:
- A microfluidic chip was designed to capture breast cancer exosomes.
- Exosomal surface proteins (CD63, EpCAM, HER2) and internal miRNAs (miRNA-21, miRNA-375) were quantified.
- Chemiluminescence and nanobeacon-based fluorescence detection methods were integrated.
- Smartphone imaging was used for protein level determination.
Main Results:
- The developed platform achieved 99.6% diagnostic accuracy for breast cancer identification.
- The five-marker panel significantly outperformed single-marker detection methods.
- This multitarget exosome analysis demonstrated high sensitivity and specificity.
Conclusions:
- The integrated microfluidic chip provides a novel, sensitive, and accurate platform for breast cancer early diagnosis.
- This multitarget exosome analysis tool is potentially low-cost and scalable.
- The platform shows promise for assessing breast cancer treatment efficacy.
